Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Fasching

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Breast Cancer Research and Treatment|February 5, 2005
A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancerGunter von Minckwitz, Walter Jonat, Peter Fasching, et al.
Immunotherapy|July 7, 2022
Cost-effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancerMin Huang, Peter Fasching, Amin Haiderali, et al.
Frontiers in Medicine|April 5, 2021
Red Cell Distribution Width Upon Hospital Admission Predicts Short-Term Mortality in Hospitalized Patients With COVID-19: A Single-Center ExperienceChristoph C Kaufmann, Amro Ahmed, Ulrich Brunner, et al.
Biosensors|September 27, 2024
Improved Glycemic Control during a One-Week Adventure Camp in Adolescents with Type 1 Diabetes-The DIACAMP StudyAntonia-Therese Kietaibl, Faisal Aziz, Eva Wurm, et al.
Diabetes Research and Clinical Practice|November 14, 2015
High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: A multicenter cohort study on 215,932 patients from the German/Austrian diabetes registryNicole Prinz, Julia Stingl, Albrecht Dapp, et al.
Breast Cancer Research and Treatment|November 25, 2024
Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markersDorothea Hanf, Peter Fasching, Paul Gass, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)]Monika Lechleitner, Susanne Kaser, Friedrich Hoppichler, et al.
Cardiovascular Diabetology|October 25, 2017
Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)Guntram Schernthaner, Roger Lehmann, Martin Prázný, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2019)]Monika Lechleitner, Susanne Kaser, Friedrich Hoppichler, et al.
Anticancer Research|September 16, 2016
Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS TrialPhilip Hepp, Ulrich Andergassen, Bernadette Jäger, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|February 5, 2005
A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancerGunter von Minckwitz, Walter Jonat, Peter Fasching, et al.
Immunotherapy|July 7, 2022
Cost-effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancerMin Huang, Peter Fasching, Amin Haiderali, et al.
Frontiers in Medicine|April 5, 2021
Red Cell Distribution Width Upon Hospital Admission Predicts Short-Term Mortality in Hospitalized Patients With COVID-19: A Single-Center ExperienceChristoph C Kaufmann, Amro Ahmed, Ulrich Brunner, et al.
Biosensors|September 27, 2024
Improved Glycemic Control during a One-Week Adventure Camp in Adolescents with Type 1 Diabetes-The DIACAMP StudyAntonia-Therese Kietaibl, Faisal Aziz, Eva Wurm, et al.
Diabetes Research and Clinical Practice|November 14, 2015
High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: A multicenter cohort study on 215,932 patients from the German/Austrian diabetes registryNicole Prinz, Julia Stingl, Albrecht Dapp, et al.
Breast Cancer Research and Treatment|November 25, 2024
Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markersDorothea Hanf, Peter Fasching, Paul Gass, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)]Monika Lechleitner, Susanne Kaser, Friedrich Hoppichler, et al.
Cardiovascular Diabetology|October 25, 2017
Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)Guntram Schernthaner, Roger Lehmann, Martin Prázný, et al.
Wiener Klinische Wochenschrift|April 14, 2019
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2019)]Monika Lechleitner, Susanne Kaser, Friedrich Hoppichler, et al.
Anticancer Research|September 16, 2016
Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS TrialPhilip Hepp, Ulrich Andergassen, Bernadette Jäger, et al.
Pageof 12